Title |
Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma
|
---|---|
Published in |
Cochrane database of systematic reviews, December 2012
|
DOI | 10.1002/14651858.cd004360.pub4 |
Pubmed ID | |
Authors |
Wei Jie Lim, Redhuan Mohammed Akram, Kristin V Carson, Satya Mysore, Nadina A Labiszewski, Jadwiga A Wedzicha, Brian H Rowe, Brian J Smith |
Abstract |
Asthma is a chronic respiratory condition causing inflammation and changes to the airways. Care of people with asthma includes routine and urgent management across primary and tertiary care; however, due to sub-optimal long-term care and delays in obtaining help during acute exacerbations, the mortality and morbidity related to asthma is still a major health concern. There is reason to believe that non-invasive positive pressure ventilation (NPPV) could be beneficial to patients with severe acute asthma; however, the evidence surrounding the efficacy of NPPV is unclear, despite its common use in clinical practice. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Chile | 1 | 25% |
Unknown | 3 | 75% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 4 | 1% |
Portugal | 2 | <1% |
Canada | 2 | <1% |
Brazil | 2 | <1% |
Korea, Republic of | 1 | <1% |
Italy | 1 | <1% |
Indonesia | 1 | <1% |
South Africa | 1 | <1% |
Hong Kong | 1 | <1% |
Other | 5 | 1% |
Unknown | 374 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 51 | 13% |
Researcher | 45 | 11% |
Other | 44 | 11% |
Student > Bachelor | 39 | 10% |
Student > Postgraduate | 30 | 8% |
Other | 85 | 22% |
Unknown | 100 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 203 | 52% |
Nursing and Health Professions | 37 | 9% |
Social Sciences | 10 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 2% |
Psychology | 6 | 2% |
Other | 26 | 7% |
Unknown | 106 | 27% |